Salute e Benessere
Kindeva bolsters executive team with Chief Quality Officer appointment
As a member of the Executive Leadership Team, Melanie will be responsible for further enhancing Kindeva's quality and compliance strategy, culture and capability.
Commenting on Melanie's appointment, Milton Boyer , CEO of Kindeva, said, "Melanie's expertise and impressive track record in FDA, EMA, and ICH regulations will be pivotal in our mission to foster operational growth and innovation across the company.
"As we continue to expand global capacity to meet the considerable demand for Kindeva's services, we remain extremely committed to ensuring that the medicines we develop and manufacture on behalf of our customers and their patients are done so to the highest standards "Melanie's proven track record of leading strategic quality initiatives across complex GMP operations will further enhance our pursuit of continuously improving our quality culture.
Kindeva is a leading global CDMO with vast expertise in drug delivery devices. Learn more about its services here.
At Kindeva, we manufacture more tomorrows for patients worldwide. With best-in-class facilities and comprehensive CDMO services, we offer more than manufacturing—we deliver strategic value. Our global network of 10 manufacturing and R&D sites offer exceptional integrated knowledge and capabilities, including Annex 1-compliant state-of-the-art aseptic fill finish capacity and next-generation sustainable inhalation propellant technology. By combining expertise in injectable, pulmonary, nasal and dermal drug delivery, we help meet the demands of today and deliver the possibilities of tomorrow. Find out more at https://www.kindevadd.com/
View original content:https://www.prnewswire.co.uk/news-releases/kindeva-bolsters-executive-team-with-chief-quality-officer-appointment-302433600.html